Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2025-12-25 @ 4:59 AM
NCT ID:
NCT04428918
Eligibility Criteria:
* INCLUSION CRITERIA:
* Diagnosis of a hematologic malignancy, immunodeficiency or disorder of T-cell proliferation and/or dysregulation
* Have undergone or planning to undergo an allogenic hematopoietic cell transplantation
* Age greater than or equal to 8 years
* Additional inclusion criteria pertinent only for patients undergoing apheresis
* Hemoglobin greater than or equal to 8 mg/dL and platelet count \> 75 K/uL
* Weight greater than or equal to 48 kg
* Adequate venous access
EXCLUSION CRITERIA:
* Active concomitant medical or psychological illnesses that may increase the risk to the subject
* Inability of subject or parent/legal guardian to provide informed consent
* Pregnant or breastfeeding women as some tests and procedures allowed are contraindicated in pregnancy (i.e., CT scans, administration of iodinated contrast)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Study:
NCT04428918
Study Brief:
Protocol Section:
NCT04428918